OCGN
Ocugen Inc
NASDAQ: OCGN · HEALTHCARE · BIOTECHNOLOGY
$1.73
+2.98% today
Updated 2026-04-30
Market cap
$557.42M
P/E ratio
—
P/S ratio
126.31x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$1 – $3
Volume
8.9M
Ocugen Inc (OCGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
8,559.00%
ROE
-777.00%
ROA
-63.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $26000.00 | $-16.93M | 100.00% | -57,569.23% | -65,134.62% |
| 2013 | $8000.00 | $-25.71M | 100.00% | -210,562.50% | -321,400.00% |
| 2014 | — | $-22.79M | — | — | — |
| 2015 | — | $-32.02M | — | — | — |
| 2016 | $0.00 | $-16.21M | — | — | — |
| 2017 | $0.00 | $-26.41M | — | — | — |
| 2018 | $0.00 | $-8.64M | — | — | — |
| 2019 | $42620.00 | $-20.24M | -18,972.31% | -33,230.88% | -47,496.48% |
| 2020 | $43000.00 | $-21.82M | -14,676.74% | -49,500.00% | -50,748.84% |
| 2021 | $22920.00 | $-58.37M | -2,569.81% | -253,176.27% | -254,646.60% |
| 2022 | $2.49M | $-77.83M | -43.13% | -3,411.09% | -3,128.38% |
| 2023 | $6.04M | $-63.08M | 88.34% | -1,085.67% | -1,045.03% |
| 2024 | $4.05M | $-54.05M | 51.47% | -1,350.36% | -1,333.02% |
| 2025 | $4.41M | $-67.85M | 45.86% | -1,425.70% | -1,537.41% |